Makes medical devices for orthopedic and reconstructive surgery.
Jul 2026Revenue $2.30B/yrExpenses $3.33B/yr
Fell below break-even Dec 2020
Figures by year
When will Enovis be profitable again?
Its expenses passed its revenue in Dec 2020. In the 12 months to Jul 2026, revenue was $2.30B and expenses $3.33B.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $2.25B | $3.37B | −$1.12B |
| Dec 2024 | $2.11B | $2.88B | −$776M |
| Dec 2023 | $1.71B | $1.77B | −$65.7M |
| Dec 2022 | $1.56B | $1.63B | −$71.2M |
| Dec 2021 | $1.43B | $1.49B | −$62.8M |
| Dec 2020 | $1.12B | $1.19B | −$66.2M |
| Dec 2019 | $3.33B | $3.12B | $204M |
| Dec 2018 | $2.19B | $2.04B | $152M |
| Dec 2017 | $1.94B | $1.80B | $136M |
| Dec 2016 | $3.19B | $2.95B | $237M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.